Tag: Cancer: Misc.
FDA Approves Yondelis for Soft-Tissue Sarcoma
Drug sanctioned for liposarcoma or leiomyosarcoma
Cancers Differ in Indigenous, Non-Indigenous Populations
Generally, indigenous cancer rates lower, except for lung cancer in men, cervical in women
Possible Association for Bortezomib Therapy, Chalazia
Twenty-four reports of bortezomib-linked chalazia, mainly involving upper eyelid
Time-Limited Strategies Feasible for ICU Critical Cancer Care
For patients with poor-prognosis solid tumors, trial duration of one to four ICU days may be sufficient
Lower-Income Cancer Patients Less Likely to Participate in Trials
Trial participation decreases with decreasing annual household income
Computerized Tool Aids Cognitive Deficits in Cancer Survivors
Findings based on small study of childhood cancer survivors with treatment-related deficits
Myopathy in Patient With Rx-Related Respiratory Symptoms
Case report describes 84-year-old male patient with myositis after nivolumab treatment
Cancer Survivors Often Have Poor Dietary Quality
Worse intake patterns than matched individuals from general population for empty calories, fiber
Young Cancer Survivors May Need Lifelong Screenings
Patients successfully treated at age 15 to 39 nearly 60 percent more likely to develop another cancer
Prognostic Disclosure Improves Life Expectancy Estimates
Prognostic disclosure linked to more realistic patient expectations in advanced cancer
